Dual diagnosis treatment for Deerfield Beach — one team, both diagnoses, together.

RECO Health is 13 miles north of Deerfield Beach — about 22 minutes via A1A or I-95 — and offers integrated dual diagnosis treatment where the same in-house psychiatrist manages MAT (buprenorphine, naltrexone, acamprosate) and psychotropic medication (SSRIs, mood stabilizers, ADHD medication) on one plan. Trauma-trained therapists deliver CPT, Prolonged Exposure, and EMDR concurrently with substance use protocols rather than sequentially, and a full continuum from detox through outpatient allows clients to step down within the same clinical team. In-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS.

Deerfield Beach sits 13 miles south of RECO Health’s Delray Beach campus — about 22 minutes up A1A or I-95, depending on traffic through The Cove and Pioneer Park. For clients coming from Hillsboro Beach, Cresthaven, or the Goldcoast Centre corridor, that short drive functions as deliberate clinical distance: enough physical separation from the people, bars, and supply chains tied to active use, but close enough that family, employers, and outpatient providers remain reachable. Dual diagnosis — the concurrent treatment of substance use disorder and a co-occurring psychiatric condition — is the presentation we see most often in that Deerfield-to-Delray corridor, and it is what the RECO Health program is built around.

Why sequential treatment fails for co-occurring disorders

The “get sober first, then we’ll deal with the depression” model is still common in South Florida treatment settings, and the outcome data on it is unambiguous. Sequential treatment produces higher relapse rates, higher psychiatric readmission rates, and worse functional recovery than integrated treatment. When the mood or anxiety diagnosis is left untreated during the addiction phase, the untreated symptoms drive early return to use — typically within the first 90 days post-discharge. When the substance use is left active during a psychiatric admission, antidepressant and mood-stabilizer response is blunted or absent.

Integrated treatment — the same clinical team, the same treatment plan, both diagnoses addressed concurrently — has been the SAMHSA standard of care for co-occurring disorders for more than two decades. Executing it, however, requires clinical staff who are dually credentialed or supervised: a psychiatrist comfortable prescribing both MAT and psychotropics, therapists trained in both substance use and mood disorder protocols, and case managers who can coordinate both tracks in real time. At RECO Health, integration is structural — it is how the program is staffed, not an add-on service.

Practically, that means a client with opioid use disorder and PTSD does not see one clinician for the OUD and a separate outside provider for the PTSD. The buprenorphine induction, the Cognitive Processing Therapy protocol, and the medication reconciliation happen inside the same building on the same weekly treatment-planning meeting.

The high-prevalence co-occurring diagnoses

Five psychiatric diagnoses account for the majority of dual diagnosis presentations: major depressive disorder, PTSD, generalized anxiety disorder, bipolar disorder, and adult ADHD. RECO screens all five at intake with validated instruments — the PHQ-9 for depression, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolar spectrum illness, and the ASRS for adult ADHD. Screening is not a formality; it drives the differential and it drives the treatment plan.

Each diagnosis has a defined evidence-based pathway within the program. Depression is treated with an SSRI such as sertraline or escitalopram alongside CBT and behavioral activation; treatment-resistant presentations are evaluated for rTMS or ketamine augmentation. PTSD is treated with CPT, Prolonged Exposure, or EMDR, sequenced after stabilization. Bipolar disorder is treated with mood-stabilizer optimization — lithium, lamotrigine, or an atypical such as quetiapine or aripiprazole — plus psychoeducation focused on sleep and stimulant avoidance. ADHD is managed with a non-stimulant first (atomoxetine, guanfacine) or, when stimulants are clinically indicated, with careful monitoring appropriate for a substance use population.

Anxiety is generally treated with SSRIs, buspirone, and exposure-based CBT rather than benzodiazepines, given the abuse liability in this cohort. When a benzodiazepine taper is medically necessary at intake, it is protocolized and monitored on the CIWA-B.

MAT and psychotropic medication managed by one psychiatrist

Fragmented prescribing is one of the most reliable relapse pathways in this population. A client discharges from detox on buprenorphine, resumes an SSRI prescribed by a primary care doctor who was never informed about the buprenorphine, picks up a sleep medication from an urgent care visit, and lands in an ED four weeks later with serotonin syndrome or a preventable withdrawal event. Integration is what closes that gap.

At RECO Health, MAT — buprenorphine or extended-release naltrexone for opioid use disorder, naltrexone or acamprosate for alcohol use disorder, and disulfiram in selected cases — is managed by the same in-house addiction psychiatrist who manages the client’s antidepressant, mood stabilizer, or ADHD medication. Interactions are considered on a single medication list. QT prolongation risk from combining methadone (when clinically indicated) with an SSRI or an antipsychotic is flagged in advance. Dosing changes are coordinated with the therapy schedule and, with consent, communicated to family.

This is the mechanism behind the RECO Health dual diagnosis treatment program: one prescriber, one plan, one medication list — not three parallel prescribers who never speak.

Trauma is often the through-line

For a substantial share of dual diagnosis clients — particularly those with opioid, alcohol, or benzodiazepine use disorders — unprocessed trauma is upstream of both the substance use and the mood or anxiety diagnosis. Screening for trauma at intake is routine; treating it prematurely is not. The RECO protocol stabilizes first: acute withdrawal is managed on CIWA-Ar for alcohol or COWS for opioids, sleep and nutrition are restored, psychiatric medication is optimized, and the client’s window of tolerance is assessed before trauma processing begins.

Once the client is stable, trauma is addressed with an evidence-based protocol — CPT, Prolonged Exposure, or EMDR — delivered by a trauma-trained therapist. Adjunctive modalities including DBT skills, ACT, and Motivational Interviewing build distress tolerance so the client can stay in-session during exposure work without dissociating or returning to use. In select treatment-resistant cases with concurrent depression, IV ketamine or intranasal esketamine is used to accelerate the therapeutic work.

Treating the substance use without addressing the underlying trauma is a common failure mode. It produces short-term abstinence and predictable long-term relapse, often clustered around the six-month mark.

What to expect on your first visit

The first appointment for a Deerfield Beach client is typically 90 minutes and covers three domains: a full psychiatric intake with a physician or psychiatric APRN, an ASAM Criteria assessment across the six dimensions to determine level of care, and a real-time insurance verification with a same-day benefits summary. Screening instruments — PHQ-9, GAD-7, PCL-5, MDQ, ASRS, and either CIWA-Ar or COWS as clinically indicated — are administered by clinical staff, not handed to the client as forms to complete alone.

A written treatment plan and a level-of-care recommendation are delivered the same day. If medical detox is indicated, admission is typically same-day or next-day; if PHP, IOP, or outpatient is the appropriate level, scheduling begins immediately and MAT induction can be initiated at that visit.

Insurance and admissions from Deerfield Beach

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS commercial plans, which covers the majority of Deerfield Beach residents on employer-sponsored coverage. The admissions team runs a real-time benefits check before the first appointment so the client knows exactly what is covered — detox days, residential days, PHP, IOP, MAT, TMS, and outpatient psychiatry. For clients in Cresthaven, The Cove, or the Hillsboro Beach corridor, ground transportation is coordinated when detox admission is same-day. Written estimates of deductible, coinsurance, and out-of-pocket maximum are provided at intake.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.